NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-148-1999-0-EP-14 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS EP National Stage 00928591.7 Expired
NIAID E-148-1999-0-CH-24 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS CH EP 00928591.7 Expired
NIAID E-148-1999-0-GB-30 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS GB EP 00928591.7 Expired
NCI E-057-1997-0-US-07 PSEUDOMONAS EXOTOXIN A-Like CHIMERIC IMMUNOGENS US National Stage 09/462,682 7314632 Abandoned PDF
NIAID E-148-1999-0-AU-05 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS AU ORD 46805/00 Expired
NCI E-230-1997-0-US-02 Antisense Oligonucleotides To Human Papilloma Virus US CON 09/560,579 6277980 Abandoned PDF
NIAID E-148-1999-0-PCT-02 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS PCT PCT PCT/US00/011612 Expired
NIAID E-148-1999-0-EP-15 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS EP DIV 09169462.0 Expired
NIAID E-148-1999-0-JP-20 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-3 and IL-13 RECEPTOR CHAINS JP DIV 2011-2569 Expired
NIAID E-148-1999-0-HK-17 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS HK EP 10105065.7 Expired
NIAID E-148-1999-0-IL-08 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS IL National Stage 146082 Expired
NIAID E-148-1999-0-MX-13 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS MX National Stage PA/a/2001/011023 Abandoned
NIAID E-148-1999-0-JP-21 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-3 and IL-13 RECEPTOR CHAINS JP DIV 2013-232738 Expired
NCI E-157-2000-0-US-01 Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines US 60/200,444 Abandoned
NCI E-159-2000-0-US-01 Immunotherapy In HIV Infeted Persons Using Vaccines After Multi-Drug Treatment US 60/200,445 Abandoned
NICHD E-163-2000-0-US-01 Use of Cumulative Distribution Functions to Determine Protein Purity And Homogeneity. US 60/200,300 Abandoned
NIAID E-148-1999-0-BR-03 TREATMENT OF FIBROSIS BY ANTAGONISM OF IL-13 and IL-13 RECEPTOR CHAINS BR National Stage PI0010061-7 Expired
NIAID E-033-1996-1-AU-08 MODIFIED MYELIN BASIC PROTEIN MOLECULES AU DIV 30223/00 Abandoned
NCI E-268-1999-0-PCT-02 Use of Semi-Allogeneic Cell Line-Peptide Complexes For The Treat of Cancer Aids And Other Viral Diseases PCT PCT PCT/US00/11008 Abandoned
NCI E-268-1999-0-US-01 USE OF SEMI-ALLOGENEIC CELL LINE-PEPTIDE COMPLEXES TO GENERATE PEPTIDE SPECIFIC T CELL RESPONSES FOR AIDS IMMUNOTHERAPY US ORD 09/254,556 Abandoned
NHLBI E-240-1998-0-PCT-02 Method for Enhancing Contrast in Images Produced by Magnetic Resonance Imaging PCT PCT PCT/US00/10878 Expired
CC E-228-1998-0-PCT-02 Novel Diagnostic Standards for Virus Detection and Quantification PCT PCT PCT/US00/10901 Abandoned
NHLBI E-240-1998-0-EP-07 Method for Enhancing Contrast Produced by MRI EP DIV 08006560.0 Abandoned
CC E-228-1998-0-EP-04 Novel Diagnostic Standards for Virus Detection and Quantification EP National Stage 00928317.7 Abandoned
NHLBI E-240-1998-0-EP-03 Method for Enhancing Contrast in Images Produced by Magnetic Resonance Imaging EP National Stage 00928307.8 Abandoned
NIAID E-096-2000-0-US-01 INDUCIBLE PLASMID VECTOR ENCODING TGF-beta AND USES THEREOF US 60/199,014 Abandoned
CC E-228-1998-0-CA-03 Novel Diagnostic Standards for Virus Detection and Quantification CA National Stage 2370957 Abandoned
NIDDK E-220-1998-0-AU-03 DNA Binding Protein And Sequence as Insulators having Specific Enhancer Blocking Activity for Regulation of Gene Expression AU National Stage 46475/00 Abandoned
NIDDK E-220-1998-0-PCT-02 DNA Binding Protein And Sequence as Insulators having Specific Enhancer Blocking Activity for Regulation of Gene Expression PCT PCT PCT/US00/10509 Expired
NIDDK E-220-1998-0-EP-05 DNA Binding Protein And Sequence as Insulators having Specific Enhancer Blocking Activity for Regulation of Gene Expression EP National Stage 00928209.6 Abandoned
NIDDK E-220-1998-0-JP-06 DNA Binding Protein And Sequence as Insulators having Specific Enhancer Blocking Activity for Regulation of Gene Expression JP National Stage 2001-508326 Abandoned
NIMH E-168-1999-0-AU-04 METHODS RELATED TO THE COMBINED USE OF IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION AU National Stage 43542/00 Abandoned
NIMH E-168-1999-0-PCT-02 COMPOSITIONS CONTAINING IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION FOR INDUCING IMMUNE TOLERANCE TO A GRAFT PCT PCT PCT/US00/10253 Expired
NICHD E-225-1997-2-US-01 Methods And Composititions For Treatment of Fribrotic Conditions & Impaired Lung function & To Enchance Lyphocyte Production US CIP 09/120,264 Abandoned
NIMH E-168-1999-0-EP-06 Compositions Containing Immunotoxins and Agents that Inhibit Dendritic Cell Maturation for Inducing Immune Tolerance to a Graft EP National Stage 00923415.4 Abandoned
NIMH E-168-1999-0-JP-07 METHODS RELATED TO THE COMBINED USE OF IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION JP National Stage 2000-610465 Abandoned
NIMH E-168-1999-0-HK-09 METHODS RELATED TO THE COMBINED USE OF IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION HK National Stage 02103064.3 Abandoned
NIMH E-168-1999-0-CA-10 METHODS RELATED TO THE COMBINED USE OF IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION CA National Stage 2382628 Abandoned
NIMH E-168-1999-0-CN-05 METHODS RELATED TO THE COMBINED USE OF IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION CN National Stage 00808770.9 Abandoned
NIMH E-168-1999-0-BR-08 METHODS RELATED TO THE COMBINED USE OF IMMUNOTOXINS AND AGENTS THAT INHIBIT DENDRITIC CELL MATURATION BR National Stage PI0009772-1 Abandoned
NICHD E-043-1999-0-CA-06 Utergolobin in The Treatment of IgA Meditated Automimmune Disorders CA National Stage 2370738 Abandoned
NICHD E-043-1999-0-EP-04 Uteroglobin in The Treatment of IgA Meditated Automimmune Disorders EP National Stage 00923335.4 Abandoned
NIMH E-185-1998-0-EP-05 High Sensitivity Phage Display Biomolecule Detection EP National Stage 00926011.8 Abandoned
NICHD E-043-1999-0-AU-03 Utergolobin in The Treatment of IgA Meditated Automimmune Disorders AU National Stage 43480/00 Abandoned
NIMH E-185-1998-0-AU-03 High Sensitivity Phage Display Biomolecule Detection AU National Stage 44612/00 Abandoned
NICHD E-043-1999-0-PCT-02 Utergolobin in the Treatment of IgA Meditated Automimmune Disorders PCT PCT PCT/US00/09979 Expired
NIMH E-185-1998-0-PCT-02 High Sensitivity Phage Display Biomolecule Detection PCT PCT PCT/US00/10146 Expired
NIMH E-185-1998-0-CA-04 High Sensitivity Phage Display Biomolecule Detection CA National Stage 2368875 Abandoned
NIMH E-185-1998-0-JP-06 High Sensitivity Phage Display Biomolecule Detection JP National Stage 2000-611713 Abandoned
NIAID E-040-1999-0-MX-12 Production of Attenuated Negative Stranded RNA Virus Vaccines From Cloned Nucleotide Sequences MX National Stage 2001-010392 Abandoned